KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Gains from Investment Securities (2020 - 2025)

Clover Health Investments' Gains from Investment Securities history spans 6 years, with the latest figure at $1000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 96.97% year-over-year to $1000.0; the TTM value through Dec 2025 reached $53000.0, down 61.03%, while the annual FY2025 figure was $20000.0, 60.0% down from the prior year.
  • Gains from Investment Securities reached $1000.0 in Q4 2025 per CLOV's latest filing, down from $19000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $134.5 million in Q2 2021 to a low of -$115.2 million in Q3 2021.
  • Average Gains from Investment Securities over 5 years is $1.7 million, with a median of $33000.0 recorded in 2024.
  • The largest YoY upside for Gains from Investment Securities was 1295.79% in 2021 against a maximum downside of 674.93% in 2021.
  • A 5-year view of Gains from Investment Securities shows it stood at $494000.0 in 2021, then tumbled by 412.15% to -$1.5 million in 2022, then surged by 105.58% to $86000.0 in 2023, then crashed by 61.63% to $33000.0 in 2024, then tumbled by 96.97% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Gains from Investment Securities are $1000.0 (Q4 2025), $19000.0 (Q2 2025), and $33000.0 (Q4 2024).